Skip to content

Comparison of Remifentanil use in spinal surgery with and without ANI monitoring guidance

Comparison of Remifentanil use in spinal surgery with and without ANI(analgesia nociception Index) monitoring guidance

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180303038923N1
Enrollment
60
Registered
2022-07-05
Start date
2018-05-21
Completion date
Unknown
Last updated
2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Remifentanil use in surgery with Analgesia Nociception Index.

Interventions

Intervention 1: Control group: Patients who are candidates for spinal surgery who undergo general anesthesia without ANI monitoring. Intervention 2: Intervention group: Patients who are candidates for

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients between 18 and 70 years Patients candidate for spine surgery ASA Grade I-II Consent to enter the study

Exclusion criteria

Exclusion criteria: Patients taking beta-blocker drugs

Design outcomes

Primary

MeasureTime frame
Dosage of remifentanil during surgery. Timepoint: During surgery. Method of measurement: The amount of remifentanil consumed.

Secondary

MeasureTime frame
The rate of pain in recovery in patients. Timepoint: 10, 20, 30 and 60 minutes during recovery. Method of measurement: Visual Analogue Scale.;Further drop in arterial blood saturation below 90% for 60 seconds. Timepoint: 10, 20, 30 and 60 minutes during recovery. Method of measurement: Pulse oximetry.;Complications of fentanyl remedies. Timepoint: During recovery. Method of measurement: According to the recovery nurse.;Global Satisfaction of patients at the end of recovery. Timepoint: At the end of recovery. Method of measurement: Based on 5 point criteria (poor, average, good, very good and excellent).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarsad Imani

Tehran University of Medical Sciences

imanifar@tums.ac.ir+98 21 6312 1278

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026